PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

M He, C Cao, Z Ni, Y Liu, P Song, S Hao, Y He… - … and Targeted Therapy, 2022 - nature.com
Abstract PROteolysis TArgeting Chimeras (PROTACs) technology is a new protein-
degradation strategy that has emerged in recent years. It uses bifunctional small molecules …

Developments of CRBN-based PROTACs as potential therapeutic agents

C Wang, Y Zhang, Y Wu, D Xing - European journal of medicinal chemistry, 2021 - Elsevier
Protease-targeted chimeras (PROTACs) are a new technology that is receiving much
attention in the treatment of diseases. The mechanism is to inhibit protein function by …

The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine

LM Monteggia, E Gideons, ET Kavalali - Biological psychiatry, 2013 - Elsevier
Major depressive disorder is a devastating mental disorder. Current antidepressant
medications can be effective for some patients with depression; however, these drugs exert …

Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles

JW Kenney, CE Moore, X Wang, CG Proud - Advances in biological …, 2014 - Elsevier
Eukaryotic elongation factor 2 kinase (eEF2K) is a member of the small group of atypical 'α-
kinases'. It phosphorylates and inhibits eukaryotic elongation factor 2, to slow down the …

Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases

R Liu, CG Proud - Acta Pharmacologica Sinica, 2016 - nature.com
Eukaryotic elongation factor 2 kinase (eEF2K) is an unusual protein kinase that regulates
the elongation stage of protein synthesis by phosphorylating and inhibiting its only known …

Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons

C Heise, F Gardoni, L Culotta, M di Luca… - Frontiers in cellular …, 2014 - frontiersin.org
Neuronal activity results in long lasting changes in synaptic structure and function by
regulating mRNA translation in dendrites. These activity dependent events yield the …

Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling

X Wang, SR da Mota, R Liu, CE Moore… - … and cellular biology, 2014 - Am Soc Microbiol
Eukaryotic elongation factor 2 kinase (eEF2K), an atypical calmodulin-dependent protein
kinase, phosphorylates and inhibits eEF2, slowing down translation elongation. eEF2K …

Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3

Y Zhou, Y Li, S Xu, J Lu, Z Zhu, S Chen… - … journal of cancer, 2020 - Wiley Online Library
Hepatocellular carcinoma (HCC) is an aggressive malignancy with increasing mortality in
China. Angiogenesis is crucial for tumor formation, development and metastasis in HCC …

Dynamic remodelling of the human host cell proteome and phosphoproteome upon enterovirus infection

P Giansanti, JRPM Strating, KAY Defourny… - Nature …, 2020 - nature.com
The group of enteroviruses contains many important pathogens for humans, including
poliovirus, coxsackievirus, rhinovirus, as well as newly emerging global health threats such …

Eukaryotic elongation factor 2 kinase (eEF2K) in cancer

X Wang, J Xie, CG Proud - Cancers, 2017 - mdpi.com
Eukaryotic elongation factor 2 kinase (eEF2K) is a highly unusual protein kinase that
negatively regulates the elongation step of protein synthesis. This step uses the vast majority …